Complete Genome Sequence of Bacillus toyonensis Strain HA0190, Isolated from a Commercial Hydroxyapatite Product Extensively Used as a Synthetic Bone Graft Substitute
- PMID: 35377175
- PMCID: PMC9022546
- DOI: 10.1128/mra.00105-22
Complete Genome Sequence of Bacillus toyonensis Strain HA0190, Isolated from a Commercial Hydroxyapatite Product Extensively Used as a Synthetic Bone Graft Substitute
Abstract
Bacillus toyonensis is a member of the Bacillus cereus group and is used as a probiotic in animal feeds and biological applications. We report the 5.8-Mbp genome sequence of strain HA0190, an isolate from a commercial hydroxyapatite nanoparticle product. The genome contains a circular chromosome and two plasmids, pBT001 and pBT002.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Rojas-Solis D, Vences-Guzmán MA, Sohlenkamp C, Santoyo G. 2020. Bacillus toyonensis COPE52 modifies lipid and fatty acid composition, exhibits antifungal activity, and stimulates growth of tomato plants under saline conditions. Curr Microbiol 77:2735–2744. doi:10.1007/s00284-020-02069-1. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous